⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1198966 | 0.54 | — | — | |
| SCHEMBL9776890 | 0.54 | — | — | |
| SCHEMBL2798222 | 0.54 | — | — | |
| SCHEMBL6324015 | 0.51 | — | — | |
| SCHEMBL17375061 | 0.51 | — | — | |
| SCHEMBL5899078 | 0.51 | — | — | |
| SCHEMBL11371754 | 0.51 | — | — | |
| SCHEMBL17920145 | 0.50 | — | — | |
| SCHEMBL14155584 | 0.50 | — | — | |
| SCHEMBL7221033 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004037166-A2 | THERAPEUTIC GUANIDINES | ISIS PHARMACEUTICALS, INC. (US) | 2004-05-06 | — | — | WO | claimed |
| WO-2004037166-A2 | THERAPEUTIC GUANIDINES | ISIS PHARMACEUTICALS, INC. (US) | 2004-05-06 | — | — | WO | disclosed |